期刊文献+

免疫脂质体在肿瘤靶向治疗中的应用 被引量:3

The Application of Immunoliposome in Targeted Therapy in Cancer
下载PDF
导出
摘要 脂质体的应用可以提高药物的治疗指数,减少药物的治疗剂量和降低药物的毒性,被脂质体包裹的药物可以顺利地到达靶向部位。目前,脂质体药物应用于许多免疫性疾病的治疗,尤其是在肿瘤的治疗中起到了重要作用。但是,要想得到比较好的效果,在免疫脂质体的应用过程需要提高脂质体包封率和靶向性,同时要降低其他因素对脂质体的吸附。 The application of liposome can increase the therapeutic index of drugs,with reducing the dose and toxicity.Drugs entrapped by liposome can be directly transported to target sites.At present,the liposomes inlaid drugs have been used to cure many immunological diseasese and especially to cure cancer.In order to get better therapy effects,it is important to promote the encapsulation rate and the specificity of target of immunoliposomes,and meanwhile reduce the non-specific absorption of other factors.
出处 《医学综述》 2011年第6期852-854,共3页 Medical Recapitulate
关键词 脂质体 免疫脂质体 肿瘤 聚乙二醇 Liposome Immunoliposomes Cancer Polyethylene glycol
  • 相关文献

参考文献19

  • 1Maruymna K. In vivo targeting by liposomes [ J ]. Biol Pharm Bull, 2000,23 ( 7 ) :791-799.
  • 2Huang A, Kennel S J, Huang L. hnmunoliposome labeling : a sensi- tive and specific method for cell surface labeling [ J ]. J Immunol Methods, 1981,46 (2) : 141-151.
  • 3Sofou S, Sgouros G. Antibody-targeted liposomes in cancer therapy and imaging[ J ]. Expert Opin Drug Deliv ,2008,5 (2) :189-204.
  • 4Bendas G. hnmunoliposomes: a promising approach to targeting cancer therapy[ J 1. BioDrugs ,2001,15 (4) :215-224.
  • 5Mm'uyama K. PEG-immunoliposome [ J ]. Biosci Rep, 2002, 22 (2) :251-266.
  • 6Straubinger RM,Arnold RD, Zhou R, et al. Antivascular and anti- tumor activities of llposome-associated drugs [ J ]. Anticancer Res, 2004,24 (2A) :397-404.
  • 7Torchilin VP, Klibanov AL, Huang L, et al. Targeted accumulation of polyethylene glycol-coated irnmunoliposomes in infarcted rabbit myocardium[ J]. FASEB J,1992,6(9) :2716-2719.
  • 8Maruyama K, Takahashi N, Tagawa T, et al. Immunoliposomes bearing polyethyleneglycol-coupled Fab' fragment show prolonged circulation time and high extravasation into targeted solid tumors in vivo[ J]. FEBS Lett, 1997,413 ( 1 ) : 177-180.
  • 9Tseng YL, Hong Rl,, Tao MH, et al. Sterically stabilized anti-idi0- type immunoliposomes improve the therapeutic efficacy of doxorubi- cin in a murine B-cell lymphoma model [ J ]. Int J Cancer, 1999,80 (5) :723-730.
  • 10Gotaskie GE, Andreassi BF. Paclitaxel: a new antimitotic chemo- therapeutic agent[ J]. Cancer Pract, 1994,2( 1 ) :27-33.

二级参考文献4

  • 1徐梁,中华医学杂志,1992年,72卷,101页
  • 2徐梁,中华医学杂志,1991年,71卷,598页
  • 3徐梁,生物化学与生物物理进展,1990年,22卷,299页
  • 4徐梁,中华消化杂志,1989年,9卷,325页

共引文献2

同被引文献6

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部